SABBY MANAGEMENT LLC 13D and 13G filings for Qualigen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-04 9:08 pm Sale | 2021-12-31 | 13G | Qualigen Therapeutics, Inc. QLGN | SABBY MANAGEMENT LLC | 0 0.000% | -3,920 (Position Closed) | Filing |
| 2021-12-06 5:04 pm Purchase | 2021-11-29 | 13G | Qualigen Therapeutics, Inc. QLGN | SABBY MANAGEMENT LLC | 3,920 11.000% | 3,920 (New Position) | Filing |